The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Final overall survival (OS) results of the phase III PROCLAIM trial: Pemetrexed (Pem), cisplatin (Cis) or etoposide (Eto), Cis plus thoracic radiation therapy (TRT) followed by consolidation cytotoxic chemotherapy (CTX) in locally advanced nonsquamous non-small cell lung cancer (nsNSCLC).
 
Suresh Senan
Honoraria - Varian Medical Systems
Research Funding - Varian Medical Systems (Inst)
 
Anthony M. Brade
No Relationships to Disclose
 
Luhua Wang
No Relationships to Disclose
 
Johan F. Vansteenkiste
Consulting or Advisory Role - Lilly (Inst)
Speakers' Bureau - Lilly
 
Shaker R. Dakhil
No Relationships to Disclose
 
Bonne Biesma
Consulting or Advisory Role - Bristol-Myers Squibb; Lilly
 
Maite Martinez Aguillo
No Relationships to Disclose
 
Joachim Aerts
Consulting or Advisory Role - Lilly
Research Funding - Lilly (Inst); Roche Pharma AG (Inst)
 
Ramaswamy Govindan
Honoraria - Boehringer Ingelheim
Consulting or Advisory Role - Abbvie; Boehringer Ingelheim; Celgene; Clovis Oncology; Genentech/Roche; GlaxoSmithKline; Helsinn Therapeutics; Merck; Pfizer
Research Funding - Abbvie (Inst); Bayer (Inst); GlaxoSmithKline (Inst); MethylGene (Inst)
Travel, Accommodations, Expenses - Boehringer Ingelheim; Celgene; Merck
 
Belén Rubio-Viqueira
Consulting or Advisory Role - Boehringer Ingelheim; Lilly
Speakers' Bureau - Lilly; Roche Pharma AG
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Lilly; MSD
 
Conrad R. Lewanski
Honoraria - Lilly
Consulting or Advisory Role - Lilly
Speakers' Bureau - Lilly
Travel, Accommodations, Expenses - Lilly
 
David R. Gandara
Honoraria - Array BioPharma; AstraZeneca; Celgene; Lilly; Novartis; Synta
Consulting or Advisory Role - Amgen; AstraZeneca; Bayer; Boehringer Ingelheim; Bristol-Myers Squibb; Celgene; Genentech; GlaxoSmithKline; Lilly; Merck; Novartis; Pfizer; Response Genetics; Sanofi; Synta
Research Funding - Abbott Laboratories (Inst); Bristol-Myers Squibb (Inst); Genentech (Inst); ImClone Systems (Inst); Lilly (Inst); Merck (Inst); Novartis (Inst); Pfizer (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Biomarin; Boehringer Ingelheim; Dava Oncology; Pfizer
 
Hak Choy
No Relationships to Disclose
 
Tony Mok
Employment - The Chinese University of Hong Kong
Honoraria - Amgen; AstraZeneca; AVEO; Biomarin; Boehringer Ingelheim; Bristol-Myers Squibb; Clovis Oncology; Eisai; Janssen; Lilly; Merck Serono; Novartis; Pfizer; Roche/Genentech; Taiho Pharmaceutical
Consulting or Advisory Role - Amgen; AstraZeneca; AVEO; Biomarin; Boehringer Ingelheim; Bristol-Myers Squibb; Clovis Oncology; Eisai; Janssen; Lilly; Merck Serono; Novartis; Pfizer; Roche/Genentech; Taiho Pharmaceutical
Speakers' Bureau - Amgen; AstraZeneca; Boehringer Ingelheim; Lilly; Merck Serono; Pfizer; Roche
Research Funding - AstraZeneca
Travel, Accommodations, Expenses - Amgen; AstraZeneca; Boehringer Ingelheim; Lilly; Merck Serono; Pfizer; Roche
 
Anwar Hossain
Employment - Lilly
 
Neill Allan Iscoe
Employment - Lilly
Stock and Other Ownership Interests - Lilly
 
Joseph Treat
Employment - Lilly
Stock and Other Ownership Interests - Lilly
 
Andrew G. Koustenis
Employment - Lilly
Stock and Other Ownership Interests - Lilly
 
Nadia Chouaki
Employment - Lilly
Leadership - Lilly
Stock and Other Ownership Interests - Lilly
 
Everett E. Vokes
Consulting or Advisory Role - Abbvie; AstraZeneca; Boehringer Ingelheim; Celgene; Clovis Oncology; Eisai; GeneCentric; Genentech; Lilly; Merck; Synta; Transgene; VentiRx